胃超塑性息肉的内镜治疗后恶性进展和复发率
Maryla H Turkot1, Marta Zaborowska2, Nastazja D Pilonis1,2,3
1Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.
由于胃过度增生息肉 (GHPs) 引起的胃癌的风险很低. 然而,内镜切除后的复发是常见的,这表明需要仔细监测和选择性治疗更大,有脚的息肉.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 内視鏡外科手術 內視鏡外科手術
背景情况:
- 对于胃高塑性息肉 (GHPs) 的管理算法缺乏足够的证据.
- 重新评估GHP的治疗标准对于患者的治疗结果至关重要.
研究的目的:
- 分析GHP中瘤进展的速度.
- 评估内镜切除后GHPs的复发率.
- 为了确定与GHPs瘤变化相关的风险因素.
主要方法:
- 从2003年到2022年,对889名被诊断为GHPs的患者进行了回顾性分析.
- 与国家癌症登记处进行交叉引用,以了解胃癌的发展.
- 在切除的GHP中评估瘤组件,并评估局部复发率.
主要成果:
- 胃癌发生在0.3%的患者中,平均随访时间为30.5个月.
- 在1.2%的切除的GHP中发现了新生病,主要是在≥20毫米的脚的息肉中.
- 患者的年龄和息肉大小与瘤有关;局部复发发生在25.1%的随访数据患者中.
结论:
- 从GHP中恶性进展的风险很低.
- 在GHP的内镜切除后的局部复发是一个重大问题.
- 由于瘤的风险较高,应优先进行内镜治疗,对于脚的GHP≥20毫米.
更多相关视频
03:01Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
Published on: August 2, 2024
10:31Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
相关概念视频
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
